Grace Therapeutics, Inc.
GRCENext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for GRCE. That does not mean none is planned.
Get an email about GRCE's next catalysts
Track Grace Therapeutics (GRCE) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
GRCE Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
GTX-104
Aneurysmal Subarachnoid Hemorrhage (aSAH)
CaPre
Hypertriglyceridemia
Lipid Lowering Medication
Hypertriglyceridemia
CaPre (TM)
Hypertriglyceridemia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
GTX-104 | Phase 3 | Aneurysmal Subarachnoid Hemorrhage (aSAH) | - | - |
CaPre | Phase 3 | Hypertriglyceridemia | - | - |
Lipid Lowering Medication | Phase 2 | Hypertriglyceridemia | - | - |
CaPre (TM) | Phase 2 | Hypertriglyceridemia | - | - |
Hypertriglyceridemia
3 drugs in this indication
Aneurysmal Subarachnoid Hemorrhage (aSAH)
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Grace Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 4 drug candidates in Grace Therapeutics, Inc.'s (GRCE) pipeline across Phase 3, Phase 2. Its lead program is CaPre (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Grace Therapeutics, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Grace Therapeutics, Inc. (GRCE) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track GRCE biotech catalysts?→
Add GRCE to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Grace Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.